Insiders HTG Molecular Diagnostics, Inc.

Equities

HTGMQ

US40434H3021

Market Closed - OTC Markets Other stock markets 01:29:20 2024-04-29 pm EDT			5-day change	1st Jan Change
0.0025 ^USD	0.00%		0.00%	+92.31%

2023	Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.	CI
2023	Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.	23-07-21	CI
Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer	23-06-05	CI
HTG Molecular Diagnostics, Inc. Announces Board Changes	22-08-18	CI
HTG Molecular Diagnostics, Inc. Announces Resignation of Harry A. George, Effective August 17, 2022	22-06-27	CI
HTG Molecular Diagnostics, Inc. Appoints Dr. Robert Spitale to Therapeutics Scientific Advisory Board	22-02-03	CI
HTG Molecular Diagnostics, Inc. Appoints Christopher P. Kiritsy to Serve as Class I Director, Member of Audit Committee	22-01-28	CI
HTG Molecular Diagnostics, Inc. appoints Jerald Radich as member of Therapeutics Scientific Advisory Board	21-12-16	CI
HTG Molecular Diagnostics, Inc. Appoints Stephen Barat as Senior Vice President of Therapeutics	21-10-05	CI
HTG Molecular Diagnostics, Inc. Announces Resignation of Timothy B. Johnson as Executive Chairman and a Member of the Board of Directors	21-01-19	CI
HTG Molecular Diagnostics, Inc. Announces Executive Changes	19-05-28	CI
HTG Molecular Diagnostics, Inc. Appoints John L. Lubniewski as a Member of the Board	19-04-02	CI
HTG Molecular Diagnostics, Inc. Announces Management Changes, Effective March 31, 2019	19-01-30	CI
HTG Molecular Diagnostics, Inc. Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program	19-01-23	CI
HTG Molecular Diagnostics, Inc. Announces Executive Changes	19-01-14	CI
HTG Molecular Diagnostics, Inc. Appoints Maureen T. Cronin as Chief Scientific Officer and Senior Vice President as of November 16, 2018	18-10-31	CI
HTG Molecular Diagnostics, Inc. Appoints Michelle R. Griffin to Its Board of Directors	18-08-16	CI
HTG Molecular Diagnostics, Inc Promotes John Lubniewski to President and Chief Operating Officer	18-04-16	CI
HTG Molecular Diagnostics, Inc. Appoints Ann F. Hanham as Chair of the Board of Directors	17-03-07	CI
HTG Molecular Diagnostics, Inc. Announces Resignation of Peter T. Bisgaard from Board of Directors	17-03-07	CI
Ann F. Hanham Joins HTG Molecular Diagnostics, Inc. to its Board of Directors	16-08-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders HTG Molecular Diagnostics, Inc.

Equities

HTGMQ

US40434H3021

Insiders

Filters